Items tagged with Advocacy
Building an Evidence Base to Advocate for TB Research (post with simple image)
TAG TB Project Co-Director Mike Frick discusses how public databases maintained by the NIH have been instrumental in supporting TAG's efforts to track global funding for TB research over time and hold governments and donors accountable to their TB research commitments.
TB CAB statement on M72/AS01E TB vaccine candidate development (post with simple image)
Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate
TB LAM testing briefs (post with simple image)
Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
MSF: Johnson & Johnson should make TB drug available for all at $1/day (post with simple image)
MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.
Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients (post with simple image)
Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.
Call to action: Pledge your support for the Global Fund (post with simple image)
Sign the petition to urge governments to fully replenish the Global Fund!
It’s Time to End Drug-Resistant Tuberculosis: The Case for Action (post with simple image)
The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.
Research, regulatory, and access considerations regarding pretomanid (post with simple image)
TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.
Community capacity building modules to accelerate DR-TB response (post with simple image)
Community capacity building modules to accelerate the response to drug-resistant TB launched at WHO meeting of national TB program managers and partners in the South-East Asia region.
Page 81 of 86 · Total posts: 0←First 80 81 82 Last→